chikungunya
viru
chikv
one
import
arbovirus
primarili
transmit
aed
though
chikv
isol
almost
five
decad
ago
howev
last
decad
wit
numer
major
outbreak
span
differ
contin
report
old
new
world
recogn
global
public
health
concern
incurs
african
genotyp
asia
asian
genotyp
america
led
massiv
unpreced
outbreak
chikv
infect
human
may
last
day
clinic
spectrum
rang
acut
infect
sever
higher
number
sever
case
indic
urgent
need
develop
safe
effect
medic
countermeasur
chikv
current
licens
vaccin
therapeut
avail
chikv
chikv
belong
famili
togavirida
genu
chikv
singlestrand
positivesens
rna
genom
encod
two
polyprotein
viz
nonstructur
structur
viral
replic
nonstructur
polyprotein
process
four
nonstructur
protein
respons
viral
replic
evas
host
defenc
mechan
addit
structur
polyprotein
process
variou
protein
c
involv
viral
particl
current
target
viral
enzym
crucial
viral
replic
believ
attract
strategi
develop
antivir
therapi
chikv
protein
multifunct
protein
ctermin
domain
act
papainlik
cystein
proteas
conserv
catalyt
dyad
cy
domain
respons
cytoplasm
cleavag
polypeptid
junction
agagii
agcap
aggyif
respect
thu
pivot
role
chikv
replic
make
potenti
antivir
target
disrupt
proteas
activ
lethal
viru
inhibit
viral
proteas
alreadi
success
exploit
develop
antivir
compound
human
immunodefici
viru
hiv
hepat
c
success
gener
immens
interest
develop
proteas
inhibitor
viral
infect
though
virusencod
proteas
emerg
import
target
antivir
intervent
challeng
exist
develop
potenti
lead
molecul
viral
proteas
one
challeng
includ
lack
effici
assay
system
screen
inhibitor
ht
format
far
candid
obtain
cellbas
cell
base
assay
low
medium
throughput
due
involv
multipl
step
moreov
exact
target
remain
unknown
specif
rel
low
thu
develop
sensit
robust
ht
assay
crucial
screen
potent
candid
specif
target
near
futur
product
recombin
proteas
crucial
develop
biochem
ht
assay
abil
screen
larg
number
small
molecul
compound
librari
ht
platform
depend
abil
produc
larg
quantiti
biolog
activ
pure
enzym
express
purif
chikv
problemat
due
low
solubl
stabil
poor
yield
mani
differ
eukaryot
prokaryot
system
appli
product
enzymat
activ
proteas
bacteri
express
system
usual
prefer
due
eas
use
inexpens
ferment
scaleup
cost
meet
greater
sinc
chikv
domain
requir
post
translat
modif
therefor
good
candid
product
bacteri
system
need
optim
suitabl
condit
scale
chikv
laboratori
well
industri
level
enzym
product
larg
scale
import
paramet
enhanc
protein
product
medium
composit
cultiv
condit
induc
concentr
induct
time
durat
mode
cultiv
optim
get
recombin
protein
high
purif
recombin
enzym
necessari
minimum
possibl
step
avoid
loss
activ
degrad
achiev
requir
level
puriti
therapeut
gener
scale
cultiv
process
optim
condit
increas
express
product
level
enzym
mani
time
comparison
shake
flask
thu
success
scalabl
product
crucial
develop
costeffect
ht
assay
platform
avoid
batch
batch
variat
fluoresc
emerg
format
choic
develop
wide
varieti
ht
screen
assay
offer
advantag
mix
measur
homogen
thu
base
abil
rchikv
cleav
synthet
fluorogen
peptid
contain
enzym
natur
cleavag
site
fretbas
ht
assay
platform
antivir
compound
screen
develop
studi
readili
appli
largescal
screen
smallmolecul
librari
fda
approv
drug
zinc
acet
znac
found
effect
studi
inhibit
rchikv
evalu
vero
cell
inhibit
chikv
replic
bp
segment
encod
chikv
amplifi
use
viral
rna
templat
two
step
rtpcr
purifi
chikv
amplicon
clone
vector
frame
glutathion
stransferas
gst
ntermin
promot
screen
select
clone
sequenc
reveal
correct
read
frame
sdspage
analysi
express
protein
induct
mm
iptg
show
express
kda
chikv
fusion
protein
dual
affin
tag
accord
densitometr
analysi
band
sdspage
gel
standard
induct
condit
mm
iptg
h
recombin
chikv
found
mainli
insolubl
inclus
bodi
wherea
small
fraction
protein
remain
solubl
form
optim
induc
concentr
temperatur
induct
time
mm
iptg
overnight
result
higher
express
level
solubl
chikv
purif
solubl
fraction
recombin
protein
l
shake
flask
cell
pellet
lysat
perform
exploit
tag
use
affin
chromatographi
nativ
condit
protein
elut
use
mm
imidazol
found
pure
gel
analysi
gst
protein
also
express
purifi
nativ
condit
use
control
confirm
digest
gst
moieti
size
neg
control
proteas
assay
yield
recombin
chikv
nativ
condit
estim
mgl
shake
flask
cultur
reactiv
purifi
chikv
evalu
use
three
differ
antibodi
ie
rabbit
polyclon
antihi
monoclon
antigst
monoclon
antibodi
recombin
fusion
protein
show
affin
react
three
antibodi
specif
band
kda
repres
recombin
chikv
fusion
protein
detect
monitor
proper
enterokinas
cleavag
fusion
protein
immunoreact
cleav
fraction
also
confirm
western
blot
analysi
use
polyclon
antibodi
band
size
kda
yield
enterokinas
cleav
purifi
protein
estim
mgl
shake
flask
cultur
supplementari
fig
differ
cultiv
media
like
luria
bertani
lb
terrif
broth
tb
super
broth
sb
modif
tri
small
scale
glycerol
found
best
among
respect
overal
yield
bioactiv
enzym
condit
optim
shake
flask
level
scale
l
cultur
l
capac
bioreactor
thu
batch
cultiv
cell
propag
broth
supplement
glycerol
cultur
induc
mm
iptg
batch
run
growth
period
dissolv
oxygen
level
maintain
use
agit
speed
rpm
air
flow
rate
maintain
lmin
along
suppli
pure
oxygen
whenev
requir
initi
level
start
declin
cours
growth
cell
figur
show
growth
profil
batch
ferment
process
studi
yield
gl
gbatch
wet
cell
past
frozen
till
use
proteas
purifi
long
term
store
pellet
reveal
loss
yield
activ
supplementari
fig
final
dri
cell
weight
gl
shake
flask
bioreactor
respect
purif
result
mgl
fusion
protein
mgl
untag
fig
e
purifi
protein
character
malditof
analysi
trypsin
digest
fusion
protein
gave
multipl
peptid
peak
peptid
chikv
peptid
gst
detect
help
mascot
search
use
ncbi
databas
fig
initi
use
fluoresc
intens
fi
base
tripeptid
substrat
bocagcmca
bocagcamc
transproteolyt
activ
assay
chikv
although
fluoresc
unit
test
reaction
substrat
found
higher
background
signal
proper
enzym
curv
time
obtain
supplementari
fig
subsequ
highli
sensit
fretbas
octapeptid
substrat
dabcylargalaglyglytyrilephes
gluedan
use
determin
activ
chikv
activ
chikv
exhibit
effici
cleavag
substrat
peptid
separ
fluorophor
amino
acid
edan
quencher
dimethylamino
phenylazo
benzoic
acid
dabcyl
result
increas
fluoresc
signal
fluoresc
profil
hydrolysi
fretbas
substrat
time
depict
fig
control
reaction
also
perform
use
reaction
without
enzym
show
chang
fluoresc
intens
final
experi
carri
estim
kinet
paramet
chikv
carri
assay
increas
substrat
concentr
fig
enzym
kinet
constant
km
vmax
deriv
respect
fig
therefor
proper
reaction
veloc
satur
curv
obtain
use
longer
fretbas
peptid
substrat
purifi
mutat
chikv
use
neg
control
chikv
abl
cleav
substrat
effici
indic
crucial
activ
supplementari
fig
buffer
assay
condit
optim
proteas
assay
optim
ph
found
lower
ph
impair
activ
significantli
comparison
higher
ph
fig
optim
temperatur
proteas
activ
found
fig
effect
glycerol
antichaotrop
agent
also
observ
glycerol
concentr
slight
increas
proteas
activ
seen
howev
increas
glycerol
concentr
result
decreas
proteas
activ
fig
result
differ
na
concentr
indic
optim
concentr
around
mm
enzym
rel
insensit
na
fig
effect
differ
dival
cation
like
studi
activ
although
affect
proteas
activ
howev
p
valu
p
valu
p
valu
decreas
proteas
activ
remark
fig
effect
differ
univers
proteas
inhibitor
also
test
enzym
complet
resist
inhibitor
serin
proteas
pmsf
trypsin
proteas
inhibitor
aspart
proteas
pepstatin
metalloproteas
edta
moder
inhibit
cystein
proteas
inhibitor
leupeptin
p
valu
follow
chymostatin
p
valu
fig
addit
sulfhydryl
reagent
nethylmaleimid
nem
p
valu
methyl
methanethiosulfon
mmt
p
valu
almost
complet
inhibit
proteas
activ
rchikv
moreov
addit
dtt
partial
restor
enzym
activ
inhibit
mmt
indic
cy
residu
catalyt
site
chikv
import
proteolyt
activ
fig
assay
valid
statist
determin
z
factor
z
factor
chikv
calcul
use
fretbas
peptid
substrat
base
signal
background
control
evalu
given
day
addit
intrapl
interpl
daytoday
variabl
calcul
cv
signaltobackground
ratio
sb
obtain
evalu
given
day
togeth
statist
paramet
confirm
high
sensit
specif
effici
assay
fig
inhibit
rchikv
znac
measur
fretbas
assay
cleavag
fluorogen
substrat
almost
complet
inhibit
mm
znac
reaction
show
chang
fluoresc
intens
monitor
h
fluoresc
plate
reader
fig
order
determin
cytotox
effect
znac
subsequ
assay
maximum
nontox
dose
mntd
determin
vero
cell
mtt
assay
mntd
valu
znac
found
show
cell
viabil
fig
antivir
activ
assess
perform
mtt
assay
chikv
infect
vero
cell
presenc
variou
concentr
znac
hpi
indic
cell
viabil
concentr
fig
viru
induc
cytopath
effect
cpe
record
hpi
show
inhibit
dosedepend
manner
fig
antivir
activ
znac
plaqu
reduct
assay
show
chikv
load
reduc
significantli
p
valu
log
reduct
follow
treatment
znac
hpi
chikv
titer
treatment
znac
pfuml
respect
hpi
compar
pfuml
viru
control
fig
immunofluoresc
assay
also
reveal
reduct
chikv
load
fluoresc
bare
detect
cell
treat
znac
compar
viru
control
fig
similar
effect
znac
treatment
chikv
also
observ
flow
cytometr
analysi
monitor
chikv
express
flow
cytometr
analysi
show
viru
infect
cell
posit
hpi
treatment
znac
cell
show
express
result
viral
reduct
fig
next
question
whether
zinc
ion
inhibit
specif
chikv
justifi
specif
zinc
ion
chikv
molecular
dock
adopt
metsit
server
suggest
residu
chikv
highest
possibl
bind
zinc
ion
pocket
near
residu
analys
bind
zinc
ion
analysi
zn
bind
show
zn
coordin
along
two
water
molecul
water
molecul
coordin
surround
fig
effect
countermeasur
includ
develop
promis
therapeut
chikv
remain
one
import
research
challeng
scientif
commun
viral
proteas
excel
target
develop
antivir
therapeut
due
crucial
role
viral
polyprotein
process
thu
prerequisit
screen
small
molecul
inhibitor
smi
chikv
standard
larg
scale
product
solubl
catalyt
activ
recombin
viral
proteas
high
yield
homogen
prokaryot
system
develop
reliabl
ht
assay
high
sensit
select
reproduc
screen
target
compound
antichikv
activ
among
variou
express
system
e
coli
one
wide
use
express
host
offer
simpl
faster
inexpens
way
obtain
larg
quantiti
recombin
use
vector
clone
chikv
provid
integr
advantag
high
level
express
purif
detect
use
either
gst
tag
gst
moieti
vector
increas
stabil
solubl
protein
well
act
chaperon
facilit
protein
typic
nonbacteri
protein
produc
form
insolubl
inact
inclus
bodi
overexpress
ecoli
therefor
optim
express
condit
induct
lower
temperatur
lower
concentr
induc
mm
iptg
overnight
led
shift
express
solubl
form
maintain
biolog
activ
proteas
develop
ht
assay
requir
larg
quantiti
activ
proteas
difficult
achiev
shake
flask
due
inher
problem
batch
batch
variat
robust
protocol
larg
scale
product
purif
rchikv
describ
far
therefor
hcdc
batch
ferment
perform
produc
larg
amount
biomass
purif
rchikv
use
l
volum
bioreactor
l
work
volum
cultiv
medium
use
batch
run
lb
glycerol
compon
growth
media
import
enhanc
product
yield
well
reduct
byproduct
format
differ
cultiv
medium
like
lb
tb
sb
modif
tri
small
scale
result
satisfactori
use
simpl
glycerol
regard
overal
yield
bioactiv
enzym
glycerol
reduc
acet
format
also
use
antifoam
final
dri
cell
weight
batch
process
found
increas
time
compar
shake
flask
cultur
work
yield
gl
wet
cell
past
upon
purif
result
mgl
mgl
activ
untag
proteas
yield
superior
shake
flask
prove
effici
easi
run
inexpens
method
product
activ
proteas
enzymat
activ
rchikv
character
use
fluoresc
substrat
fluorescencebas
approach
wide
use
assay
proteas
drug
target
mainli
high
sensit
develop
ht
assay
two
differ
approach
use
measur
proteas
activ
ie
fi
fret
base
success
fi
base
assay
remain
ambigu
though
report
success
studi
bocaggmca
substrat
use
fi
assay
although
floresc
unit
test
reaction
found
higher
background
signal
proper
enzym
curv
time
obtain
therefor
tri
similar
type
substrat
bocaggamc
differ
fluorophor
amc
similar
result
observ
subsequ
fret
base
substrat
dabcyl
raggyif
eedan
use
success
fret
base
substrat
report
superior
fi
base
substrat
character
endopeptidas
due
low
background
cleavag
site
prefer
chikv
enzym
sinc
substrat
prefer
cleavag
use
studi
mutat
proteas
chikv
use
neg
control
abl
cleav
substrat
effici
indic
crucial
activ
alphaviru
proteas
papain
like
cystein
proteas
catalyt
dyad
consist
conserv
cy
cy
residu
act
nucleophil
activ
site
enzym
thu
biochem
activ
purifi
chikv
evalu
gener
irrevers
nem
revers
mmt
inhibitor
commonli
use
biochem
studi
involv
thioldepend
enzym
expect
addit
sulfhydryl
reagent
mmt
nem
strongli
inhibit
chikv
proteas
activ
moreov
addit
dtt
restor
enzym
activ
inhibit
mmt
therebi
confirm
cy
requir
catalysi
polyprotein
process
chikv
cystein
optim
temperatur
proteas
activ
found
correspond
well
appropri
environ
chikv
growth
vector
corrobor
fact
replic
rate
chikv
higher
mosquito
cell
compar
mammalian
effect
differ
univers
proteas
inhibitor
also
test
enzym
complet
resist
inhibitor
serin
proteas
pmsf
trypsin
proteas
inhibitor
aspart
proteas
pepstatin
metalloproteas
edta
moder
inhibit
cystein
proteas
inhibitor
leupeptin
follow
chymostatin
report
inhibit
papain
untag
tag
proteas
capabl
hydrolys
dabcyl
raggyif
eedan
substrat
howev
avoid
interfer
fusion
tag
proteas
activ
advantag
remov
fusion
tag
prior
use
therefor
subsequ
experi
carri
use
untag
kinet
without
histag
recent
studi
interfer
proteas
effect
differ
dival
cation
like
also
studi
activ
dival
cation
remark
decreas
proteas
activ
zinc
conjug
proven
effect
inhibit
sarscov
replic
vivo
identifi
inhibit
viral
proteas
biochem
thu
interest
test
influenc
metal
conjug
compound
chikv
proteas
activ
first
examin
znac
biochem
assay
inhibit
proteas
similarli
like
znac
fda
approv
drug
alreadi
use
therapeut
therefor
test
efficaci
znac
inhibit
chikv
vero
cell
interestingli
found
significantli
inhibit
chikv
titer
log
mechan
action
znac
success
report
wilson
diseas
act
metallothionein
famili
cysteinerich
therefor
znac
might
also
inhibit
chikv
cystein
proteas
similar
manner
dock
studi
show
zinc
highest
possibl
bind
catalyt
dyad
cy
activ
site
similar
zinc
coordin
site
observ
crystal
structur
mammalian
no
regul
dimethylarginin
dimethylaminohydrolas
residu
along
two
water
molecul
stabil
zn
ion
activ
structur
mammalian
no
regul
dimethylarginin
dimethylaminohydrolas
along
two
water
molecul
stabil
zn
ion
activ
site
residu
show
coordin
water
therefor
open
scope
repurpos
znac
test
fda
approv
metal
conjug
drug
chikv
offer
signific
advantag
respect
fast
track
drug
develop
advantag
cell
free
biochem
assay
includ
requir
high
contain
facil
better
access
compound
target
welldefin
mechan
action
possibl
develop
inexpens
screen
easi
adapt
newer
technolog
amen
miniatur
readi
autom
thu
robust
sensit
method
identif
inhibitor
ht
format
develop
goal
identifi
compound
antichikv
drug
activ
optim
signal
window
sb
assay
determin
favour
assay
paramet
ph
temperatur
salt
toler
assay
buffer
assay
stabil
volum
final
optim
assay
statist
valid
use
fretbas
ht
biochem
assay
screen
smi
low
variabl
thu
reliabl
reproduc
assay
develop
z
factor
intrapl
interpl
day
day
variabl
cv
platform
provid
opportun
identif
potent
inhibitor
subsequ
use
lead
molecul
would
potenti
provid
drug
capabl
treat
chikv
infect
near
futur
identif
zinc
conjug
znac
inhibitor
chikv
studi
provid
opportun
repurpos
kind
approv
drug
miner
supplement
antivir
therapi
chikv
infect
indian
isol
chikungunya
viru
genbank
access
number
propag
cell
aed
albopictu
larval
cell
use
standard
viru
adsorpt
techniqu
chikungunya
viru
handl
biosafeti
level
bsl
laboratori
vero
cell
african
green
monkey
kidney
cell
use
viral
quantif
antivir
viral
rna
extract
chikv
infect
cell
use
qiaamp
viral
rna
mini
kit
qiagen
germani
accord
manufactur
instruct
genom
region
code
amplifi
employ
design
primer
fp
rp
twostep
rtpcr
use
mmlv
rt
pfu
dna
polymeras
promega
usa
clone
ncoi
xhoi
site
express
vector
plasmid
transform
ecoli
transform
cell
cultur
luria
bertani
lb
medium
contain
kanamycin
express
induc
mm
iptg
cultur
incub
h
express
profil
studi
sdspage
prior
largescal
cell
growth
purif
rchikv
fusion
protein
produc
small
scale
assess
solubl
amount
fusion
protein
solubl
fraction
crude
cell
lysat
compar
total
amount
fusion
protein
cell
sdspage
order
shift
express
solubl
form
two
simpl
strategi
adopt
viz
lower
concentr
induc
mm
mm
iptg
induct
lower
temperatur
overnight
optim
shake
flask
cultiv
carri
l
lb
medium
presenc
kanamycin
midlog
phase
cultur
induc
mm
iptg
grown
overnight
harvest
purifi
use
affin
chromatographi
follow
purif
peak
fraction
pool
desalt
enterokinas
digest
carri
concentr
purifi
protein
estim
bicinchonin
acid
bca
sigma
usa
western
blot
analysi
use
rabbit
polyclon
kind
gift
dr
soma
chattopadhyay
institut
life
scienc
bhubaneswar
antihi
monoclon
qiagen
germani
antigst
monoclon
qiagen
germani
antibodi
use
confirm
express
rchikv
gst
protein
also
purifi
control
reaction
use
protocol
describ
mutat
conserv
catalyt
residu
ala
done
use
mutant
neg
control
fret
proteolyt
assay
sitedirect
mutagenesi
experi
carri
use
mutagen
primer
cy
ala
mutat
clone
carri
vector
mutat
isol
plasmid
confirm
dna
sequenc
mutat
proteas
express
purifi
detag
use
procedur
similar
wild
type
chikv
prior
largescal
cultiv
differ
media
like
lb
tb
sb
modif
tri
small
scale
enhanc
protein
product
optim
bioreactor
bioflo
bioreactor
new
brunswick
scientif
usa
cultiv
carri
batch
mode
use
biocommand
bioprocess
softwar
new
brunswick
scientif
usa
regul
record
batch
run
use
glycerol
inocul
batch
run
ml
stock
cultur
rchikv
e
coli
cell
inocul
l
flask
contain
ml
lb
grown
h
rpm
ml
grown
cultur
asept
inocul
l
flask
contain
ml
steril
modifi
lb
medium
glycerol
kanamycin
grown
overnight
continu
shake
rpm
thereaft
ml
overnight
grown
cultur
asept
inocul
l
capac
bioreactor
contain
l
steril
medium
glycerol
kanamycin
agit
ph
temperatur
air
flow
rate
initi
set
rpm
respect
ph
control
use
ammonium
hydroxid
maintain
satur
control
dissolv
oxygen
cascad
agit
rpm
pure
oxygen
suppli
requir
foam
prevent
use
antifoam
agent
run
cultur
grown
till
mid
log
phase
five
hour
post
inocul
cultur
induc
mm
iptg
induct
process
set
paramet
kept
ident
except
temperatur
decreas
maintain
sampl
collect
cours
run
measur
optic
densiti
drycel
weight
dcw
wetcel
weight
wcw
analysi
ferment
downstream
process
carri
current
good
manufactur
practic
cgmp
compliant
facil
class
respect
bacteri
pellet
resuspend
lysi
buffer
mm
mm
nacl
mm
imidazol
ph
wv
incub
ice
min
cell
disrupt
use
dyno
mill
willi
bachofen
ag
maschinenfabrik
switzerland
clarifi
solubl
fraction
collect
centrifug
g
min
filter
membran
remov
particul
appli
column
contain
preequilibr
superflow
resin
qiagen
usa
connect
akta
explor
ge
healthcar
life
scienc
sweden
column
first
wash
wash
buffer
mm
mm
nacl
mm
imidazol
ph
follow
wash
buffer
mm
mm
nacl
mm
imidazol
ph
protein
fraction
elut
elut
buffer
mm
mm
nacl
mm
imidazol
ph
analyz
sdspage
follow
purif
peak
fraction
pool
desalt
use
pb
exchang
buffer
untag
concentr
purifi
protein
estim
store
mass
spectrometri
analysi
rchikv
fusion
protein
sampl
run
sdspage
gel
correspond
band
protein
excis
process
use
protocol
describ
spectra
evalu
use
flex
analysi
softwar
bruker
dalton
usa
ms
spectra
obtain
submit
mascot
search
engin
via
bio
tool
version
nation
center
biotechnolog
inform
ncbi
protein
databas
use
search
initi
fi
base
substrat
bocaggmca
bocagcamc
use
proteas
assay
proteas
activ
could
detect
substrat
thu
fretbas
substrat
employ
dabcyl
raggyif
eedan
biolink
india
substrat
differ
concentr
rang
assay
buffer
mm
bistrispropan
ph
ad
nunc
well
black
plate
proteas
dilut
buffer
triplic
kinet
measur
fluoresc
read
measur
min
interv
h
use
synergi
multimod
plate
reader
softwar
biotek
usa
excit
wavelength
nm
emiss
wavelength
nm
cleavag
reaction
initi
perform
differ
time
point
h
rel
fluoresc
unit
rfu
measur
subtract
background
fluoresc
nc
time
point
h
later
select
linear
phase
cleavag
activ
subsequ
experi
determin
amount
fluorophor
releas
eedan
standard
curv
plot
character
biochem
properti
proteas
activ
measur
vari
reaction
condit
ph
temperatur
salt
content
mm
nacl
follow
treatment
variou
cystein
serin
aspartyl
metalloproteas
inhibitor
leupeptin
trypsin
proteas
inhibitor
chymostatin
pepstatin
pmsf
edta
sigma
usa
examin
effect
variou
dival
cation
proteas
activ
supplement
reaction
mm
final
known
inhibitor
cystein
proteas
nem
mmt
examin
determin
effect
activ
proteas
activ
measur
black
plate
replic
posit
neg
control
final
conduct
rigor
evalu
assay
variabl
plate
uniform
calcul
z
factor
coeffici
variat
signaltobackground
ratio
sb
signaltonois
ratio
sn
carri
antichikv
activ
znac
mm
sigma
usa
evalu
biochem
assay
reaction
volum
fluoresc
measur
monitor
releas
edan
everi
min
h
percent
inhibit
valu
calcul
rfu
obtain
presenc
absenc
znac
evalu
abil
znac
block
chikv
replic
cytotox
effect
znac
determin
use
mtt
bromid
assay
vero
cell
vero
cell
seed
cultur
plate
cell
densiti
cell
per
well
allow
overnight
incub
cell
attach
serial
twofold
dilut
compound
prepar
mem
mm
plate
incub
hour
hour
incub
mtt
solut
ad
well
incub
hour
absorb
measur
nm
mntd
determin
inhibit
assay
vero
cell
infect
chikv
multipl
infect
moi
except
cell
control
znac
ad
hour
follow
viral
adsorpt
concentr
rang
plate
incub
h
infect
supernat
collect
h
post
infect
hpi
quantit
infecti
viru
plaqu
assay
cell
viabil
examin
remain
cell
mtt
test
test
reduct
viral
load
znac
treatment
plaqu
assay
immunofluoresc
assay
reduct
cpe
carri
describ
flow
cytometr
analysi
cell
infect
chikv
moi
cell
cultur
flask
follow
treatment
znac
post
treatment
mode
infect
allow
proceed
hpi
mock
vero
cell
chikv
infect
cell
without
znac
detach
trypsin
cell
harvest
fix
chill
methanol
min
ice
permeabil
tritonx
bsapb
min
block
bsapb
min
rt
cell
probe
primari
antibodi
chikv
bsapb
incub
min
rt
follow
wash
cell
thrice
centrifug
g
min
ice
cold
pb
secondari
antibodi
antimous
fitc
bsapb
ad
incub
min
rt
dark
wash
repeat
cell
resuspend
ice
cold
bsapb
acquir
facscaliburtm
flow
cytomet
analyz
cellquest
pro
softwar
bd
bioscienc
usa
metsit
server
http
bioinfcsuclacukstructur
use
predict
zinc
bind
site
chikv
sequenc
protein
given
input
server
crystal
structur
chikv
pdb
id
use
analysi
predict
zinc
bind
site
zinc
ion
water
molecul
place
structur
use
coot
enzym
kinet
initi
veloc
calcul
use
linear
regress
function
microsoft
offic
excel
softwar
data
analyz
plot
use
michaelismenten
equat
graphpad
prism
obtain
kinet
paramet
evalu
robust
ht
proteas
assay
z
factor
cv
sb
sn
calcul
assay
perform
triplic
result
graph
error
bar
indic
sd
inhibit
assay
antivir
data
analyz
use
student
ttest
p
valu
consid
statist
signific
data
gener
analys
studi
includ
articl
supplementari
inform
file
